Phase 1 Angina Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)

Angina Patients With Non-obstructive Coronary Artery Disease

University of Virginia150 enrolled1 locationNCT06600178

Completed

Phase 1

A Dose-Escalation Safety Study of Yindan Softgels in Healthy Subjects

ischemic stroke sequelaeunstable angina pectoris of coronary heart disease (CHD)

Axeon Research (Au) Pty Ltd.40 enrolled1 locationACTRN12618000582257

Completed

Phase 1

A Phase I, Open-Label, Pharmacokinetic Study of ivabradine in healthy Chinese volunteers

Chronic Stable Angina Pectoris

Jiangsu Hengrui Medicine Co,. Ltd36 enrolled1 locationACTRN12613000277741